We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Free and Cued Selective Reminding Test (16-words) Turkish Adaptation Study (SIHT-16)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05756231
Recruitment Status : Completed
First Posted : March 6, 2023
Last Update Posted : March 6, 2023
Sponsor:
Information provided by (Responsible Party):
Jbid DURSUN UNCU, Istanbul University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
An Adaptation Study of Free and Cued Selective Reminding Test in Turkish

Condition or disease Intervention/treatment Phase
Dementia Memory Impairment Behavioral: SIHT-16 Not Applicable

Detailed Description:
As very commonly used for objectifying Alzheimer Disease memory deficits, an adaptive selection of word choices are done for the use of free and cued selective reminding test (FCSRT) procedure in Turkish population. In this study the validity and reliability of the test to measure memory deficits in persons with memory complaints will be discussed.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 270 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Screening
Official Title: Free and Cued Selective Reminding Test (16-words) Turkish Adaptation Study
Actual Study Start Date : January 5, 2020
Actual Primary Completion Date : January 26, 2023
Actual Study Completion Date : February 20, 2023

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dementia Memory

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Turkish Adaptation Study of Free and Cued Selective Reminding Test (SIHT-16)
Outcomes of Turkish adaptation of Free and cued selective reminding test (SIHT-16) is compared with memory and non-memory test in three alternative lists: a,b, and c parallel lists. The participants are assessed in neurological diagnosis routine.
 Behavioral: SIHT-16
a pencil-paper assessment tool.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Validity of translation [ Time Frame: once ]
    Variances of answers given to each form will be compared to each other to know if they are similar or different.

  2. Factor Analyses [ Time Frame: once ]
    Factor Analyses must be conducted to redefine the weight of each item on measuring memory deficits to be sure that turkish words version is similar to original factor weights.

  3. Validity of the ability of the measure to objectify the memory deficit in dementia [ Time Frame: once ]
    Test measures must be sensitive enough to objectify a memory deficits even in early stages of dementia. The scores of memory test in early and late stages of dementia will be compared to see if they are different. It's expected to be different.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • having memory complaints
  • demanding clinical consultation for the memory complaint

Exclusion Criteria:

  • vascular pathology
  • extrapyramidal findings
  • psychiatric illness
  • epilepsy
  • cognition affecting drug use
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05756231


Locations
Layout table for location information
Turkey
Istanbul University
Istanbul, Turkey, 34340
Sponsors and Collaborators
Istanbul University
Investigators
Layout table for investigator information
Study Director: İ. Hakan Gürvit, Prof. MD. Istanbul University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Jbid DURSUN UNCU, Clinical Neuropsychologist, Istanbul University
ClinicalTrials.gov Identifier: NCT05756231    
Other Study ID Numbers: 2019/778
First Posted: March 6, 2023    Key Record Dates
Last Update Posted: March 6, 2023
Last Verified: February 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Jbid DURSUN UNCU, Istanbul University:
Alzheimer Disease
Memory Complaint
Memory
Dementia
 Free and Cued Selective Reminding Test
Adaptation
Validity
Additional relevant MeSH terms:
Layout table for MeSH terms
Dementia
Brain Diseases
Central Nervous System Diseases
 Nervous System Diseases
Neurocognitive Disorders
Mental Disorders